Geneus Technologies (Chengdu) Co., Ltd.
PrivateLast Round
Series B
Mar 3, 2025
Total Funding Raised
$31.53M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Geneus Technologies (Chengdu) Co., Ltd. is a biotechnology company that develops and commercializes fourth-generation nanopore gene sequencers and related reagents for clinical and research applications.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Medical Devices, Biotech Equipment, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Geneus Technologies (Chengdu) Co., Ltd. Comparables
Compare Geneus Technologies (Chengdu) Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Qitan Tech | 89% | |
| Anxuyuan Biotechnology (Shenzhen) Co., Ltd. | 87% | |
| Ruhan Gene Tech | 79% |
Geneus Technologies (Chengdu) Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series B | Mar 3, 2025 | ||||
| Series B | Mar 2, 2023 | ||||
| Series B | Sep 29, 2021 | ||||
| Series A | Jul 31, 2020 | ||||
| Angel | Jan 29, 2018 |
Geneus Technologies (Chengdu) Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Wedo Venture Partners | Series B, Series A |
| Co-Win Ventures | Angel |
| 健壹资本 | Series B |
| GF Xinde Investment Management | Series B |
| Shenzhen Dachen Caizhi Venture Capital Management | Series B, Series A |
| Grand Mount Capital | Series B |
| 华创资本 | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 25, 2026
Monthly visitors grew 62% MoM, reaching 2.6K.
- May 16, 2026
Monthly visitors increased 52% month-over-month.
Geneus Technologies (Chengdu) Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Geneus Technologies (Chengdu) Co., Ltd.'s valuation, stock price, and market status.
Is Geneus Technologies (Chengdu) Co., Ltd. a public or private company?
Geneus Technologies (Chengdu) Co., Ltd. is a private company.
What is the current stock price of Geneus Technologies (Chengdu) Co., Ltd.?
Geneus Technologies (Chengdu) Co., Ltd. is a private company with no public stock price. No recent secondary market data is available.
How much is Geneus Technologies (Chengdu) Co., Ltd. worth (valuation)?
Valuation information for Geneus Technologies (Chengdu) Co., Ltd. is not publicly available.
Can I buy Geneus Technologies (Chengdu) Co., Ltd. stock?
Geneus Technologies (Chengdu) Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Geneus Technologies (Chengdu) Co., Ltd.'s last funding round?
Geneus Technologies (Chengdu) Co., Ltd.'s most recent funding round was Series B on March 3, 2025.
Who are the main investors in Geneus Technologies (Chengdu) Co., Ltd.?
Key investors in Geneus Technologies (Chengdu) Co., Ltd. include Co-Win Ventures, GF Xinde Investment Management, Wedo Capital, 华创资本.
Will Geneus Technologies (Chengdu) Co., Ltd. IPO soon?
No public IPO plans have been announced for Geneus Technologies (Chengdu) Co., Ltd..
How can I track Geneus Technologies (Chengdu) Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Geneus Technologies (Chengdu) Co., Ltd.'s secondary market activity and sign up for updates.